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The membrane protein MiRP3 regulates Kv4.2 channels
in a KChIP-dependent manner
Daniel I. Levy1,2, Egle Cepaitis1, Sherry Wanderling1, Peter T. Toth1, Stephen L. Archer1
and Steve A. N. Goldstein2
1Departments of Medicine and 2Pediatrics and the Institute for Molecular Pediatric Sciences, Biological Sciences Division, Pritzker School of Medicine,
University of Chicago, Chicago, IL 60637, USA
MiRP3, the single-span membrane protein encoded by KCNE4, is localized by
immunofluorescencemicroscopy to the transverse tubules ofmurine cardiacmyocytes.MiRP3 is
found to co-localize with Kv4.2 subunits that contribute to cardiac transient outward potassium
currents (I to). Whole-cell, voltage-clamp recordings of human MiRP3 and Kv4.2 expressed in
a clonal cell line (tsA201) reveal MiRP3 to modulate Kv4.2 current activation, inactivation
and recovery from inactivation. MiRP3 shifts the half-maximal voltage for activation (V 1/2)
∼20mV and slows time to peak∼100%. In addition, MiRP3 slows inactivation∼100%, speeds
recovery from inactivation ∼30%, and enhances restored currents so they ‘overshoot’ baseline
levels. The cytoplasmic accessory subunit KChIP2 also assembles with Kv4.2 in tsA201 cells to
increase peak current, shift V 1/2 ∼5mV, slow time to peak ∼10%, slow inactivation ∼100%,
and speed recovery from inactivation ∼250% without overshoot. Simultaneous expression of
all three subunits yields a biophysical profile unlike either accessory subunit alone, abolishes
MiRP3-induced overshoot, and allows biochemical isolation of the ternary complex. Thus,
regional heterogeneity in cardiac expression of MiRP3, Kv4.2 and KChIP2 in health and disease
may establish the local attributes and magnitude of cardiac I to.
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Introduction
MinK-related peptides (MiRPs) are single-span
membrane proteins that assemble with voltage-gated K+
channels to establish channel behaviour in native cells
(Abbott & Goldstein, 1998; McCrossan & Abbott, 2004).
Although the KCNE4 gene encoding MiRP subtype 3
(MiRP3) is widely expressed (Grunnet et al. 2002), the
roles of MiRP3 in natural physiology remain poorly
understood. Levels of the KCNE4 transcript in human
cardiac ventricle are robust and increase in patients with
congestive failure (Bendahhou et al. 2005; Lundquist
et al. 2005; Radicke et al. 2006), suggesting a regulatory
function for MiRP3 in the heart.
In experimental settings, MiRP3 inhibits the activity
of KCNQ1 channel subunits. Coexpression with MiRP3
markedly reduces KCNQ1 currents in heterologous cells
by direct subunit–subunit interactions via an as-yet
unidentifiedmechanism(Grunnet et al.2002;Manderfield
et al. 2009; Vanoye et al. 2009). Likewise, transient
expression of MiRP3 in Chinese hamster ovary (CHO)
cells suppresses current resulting from stable expression
of KCNQ1 with MinK (Lundquist et al. 2005), the two
subunits that produce the slow cardiac delayed rectifier
current IKs (Barhanin et al. 1996; Sanguinetti et al.
1996; Splawski et al. 1997; Sesti & Goldstein, 1998).
The observation that MiRP3 forms a ternary complex
with KCNQ1 and MinK in CHO cells suggests it may
down-regulate native IKs currents (Manderfield &George,
2008).
In a species-dependentmanner, Kv4.3 or Kv4.2 produce
cardiac I to,fast (Rosati et al. 2001; Patel et al. 2002; Guo et al.
2005; Niwa et al. 2008) channels by assembly with KChIP2
cytoplasmic accessory subunits (An et al. 2000; Kuo et al.
2001); a subpopulationofmyocytes employKv1.4 to create
I to,slow channels (Guo et al. 1999;Niwa&Nerbonne, 2010).
Hereafter in this report, I to refers solely to I to,fast. Both
Kv4.3/Kv4.2 and KChIP2 show heterogeneity in protein
and transcript levels across the healthy ventricular wall
(Patel & Campbell, 2005) and KChIP2 transcription is
reduced in human heart failure (Radicke et al. 2006).
Homologues of MiRP3 and Kv4.2 are found to inter-
act in chemosensory and mechanosensory neurons of
the nematode C. elegans (Bianchi et al. 2003). Further,
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expression ofMiRP3 with Kv4.3 and KChIP2 in CHO cells
is reported to alter channel function (Radicke et al. 2006).
Based on the high levels of KCNE4 mRNA in
myocardium and functional effects of MiRP3 on Kv4.3
with KChIP2 in tissue culture cells, we sought further
evidence for modulation of cardiac I to by MiRP3. Here,
MiRP3 andKv4.2 are found to co-localize to the transverse
tubules (T-tubules) of rat cardiac myocytes. In tsA201
cells, voltage-clamp studies demonstrate thatMiRP3 slows
Kv4.2 activation and inactivation and induces larger than
baseline currents on recovery from inactivation (over-
shoot), effects that are different from those of KChIP2
alone. Expression of Kv4.2, KChIP2 and MiRP3 in tissue
culture cells reveals formation of a ternary complex
by co-immunoprecipitation and biophysical parameters
under voltage-clamp that cannot accrue frommixtures of
Kv4.2–KChIP2 and Kv4.2–MiRP3 channels. We therefore
support the hypothesis of Radicke et al. (2006) that native
cardiac I to operates in a manner that reflects the balance
of local expression of these proteins.
Methods
Molecular biology
Human coding sequences for MiRP3 (KCNE4;
NM 080671), Kv4.2 (KCND2; NM 012281) andKChIP2.1
(KCNIP2, variant 3; NM 173192) were subcloned with
a Kozak consensus sequence (GCCACC) before the
initiating methionine into the pRAT vector, which is
optimized for both oocyte and mammalian expression
(Bockenhauer et al. 2001). An epitope-tagged variant
of Kv4.2 (Kv4.2–1d4) was engineered by introducing a
linker (RVPDGDPD) followed by the bacterial rhodopsin
sequence, 1d4 (ETSQVAPA), at the carboxy terminus.
The interacting sequence of filamin A was similarly
subcloned into pRAT with the 1d4 epitope tag (fil–1d4).
For co-transfection of Kv4.2 and KChIP2 into tsA201,
a pIRES vector was used containing KChIP2 in the 5′
multiple cloning site (MCS) and Kv4.2 in the 3′ MCS.
Antibodies
Generation of rabbit polyclonal antibodies to human
MiRP3 residues 136–150 (for immunofluorescence
studies) and 151–170 (for biochemistry) has been
described previously (Levy et al. 2008). The MiRP3136−150
antibody was directly conjugated with the Alexa Fluor
594 carboxylic, succinimidyl ester reagent (Invitrogen,
Carlsbad, CA, USA) using the protocol supplied by
the company. Anti-Kv4 antibodies were similarly raised
and affinity purified, using the peptide sequence
CLEKTTNHEFVDEQVFEES, first described by Yao et al.
(1999).Goat polyclonal antibody toMiRP3was purchased
from Santa Cruz Biotechnology (N-14; Santa Cruz,
CA, USA). Rabbit polyclonal antibody to Kv4.2 for
confirmatory immunofluorescence studies was purchased
fromChemicon/Millipore (AB5360; Temecula, CA,USA).
Mousemonoclonal antibodieswere purchased forKChIP2
(K60/73; UC Davis/NINDS/NIMH NeuroMab Facility,
Davis, CA, USA) and the 1d4 epitope (National Cell
Culture Center, Minneapolis, MN, USA).
Immunofluorescence
The animal experimentationwas conducted in accordance
with the Guide for Care and Use of Laboratory
Animals (National Institutes of Health, Bethesda, MD,
USA) and was approved by the local Institutional
Animal Care and Use Committees. Following a lethal
dose of pentobarbital (120mg kg−1), the heart was
removed from a Sprague–Dawley rat and snap-frozen
for histological sectioning. Sections 7μm thick were
fixed with cold methanol, blocked in 5% chicken
serum, and stained overnight at 4◦C with a 1:100
dilution of rabbit anti-Kv4 antibody. An Alexa Fluor
488 chicken anti-rabbit secondary IgG was applied for
1 h at room temperature before a second overnight
incubation with a 1:100 dilution of rabbit anti-
MiRP3136−150 directly conjugated to Alexa Fluor 594.
Samples were mounted with ProLong Gold antifade
reagent containing4′,6-diamidino-2-phenylindole (DAPI;
Invitrogen) and then imaged by confocal microscopy with
an α Plan-Apochromat 100×/1.46 objective.
Cell culture and transfection
Renal fibroblast cells (COS-7) and a T antigen-
transformed clone of human embryonic kidney-293 cells
(tsA201) were cultured in DMEM supplemented with
10% fetal bovine serum or newborn bovine serum,
respectively. Melanoma M2 and A7 cell lines (kindly
provided by Dr Fumihiko Nakamura) were grown in
MEMwith 10mM Hepes, 8% newborn bovine serum and
2% fetal bovine serum; the A7 cells were supplemented
with 200μgml−1 of active G418. All media contained
penicillin (100 uml−1) and streptomycin (100μgml−1),
and cells were held at 37◦C in humidified air with 5%CO2.
For patch-clamp experiments, tsA201 cells were trans-
fected with 3–6μg of plasmid DNA (including 0.25μg
of pEGFP vector; Clontech, Palo Alto, CA, USA) in
T-25 flasks, by adding 200μl of calcium–phosphate–DNA
buffer (CalPhos; Clontech) to 1.8 ml of medium;
transfected cells were rinsed and passaged 2 h later into
35mm culture dishes containing glass coverslips. In
these experiments, the molar ratio of transfected DNA
for MiRP3:Kv4.2 was 4:1, and for MiRP3:Kv4.2:KChIP2
was 4:1:1. For biochemistry experiments, tsA201 cell
C© 2010 The Authors. Journal compilation C© 2010 The Physiological Society
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transfections were scaled up to accommodate 35–40μg
of plasmid DNA in 150mm dishes. COS-7, M2 and
A7 cells were transfected with 20–30μg of plasmid
DNA in 150mm dishes by adding 2μl Lipofectamine
per 1μg DNA in accordance with the manufacturer’s
protocol. Cells were rinsed with fresh medium after 2 h
and harvested 12–36 h later. Media, sera, antibiotics and
Lipofectamine 2000 were purchased from Invitrogen.
Patch-clamp experiments
Whole-cell recordings from tsA201 cells were made
16–36 h after transfection, using an Axopatch 200A
amplifier (Axon Instruments) and CLAMPEX software.
Transfected cells were identified as those with green
fluorescence during brief illumination with a mercury
lamp, and typically represented 25% of the total
population of cells. Pipette solution contained (in
mM): 120 KF, 10 Hepes, 11 EGTA (free acid), 2MgCl2,
1 CaCl2; titrated to pH 7.20 with∼30 KOH. Bath solution
contained 150 NaCl, 10 Hepes, 2 KCl, 1MgCl2, 1.5 CaCl2;
titrated to pH 7.40 with ∼5 NaOH. Macroscopic
recordings of 1–16 nA were made at room temperature
with borosilicate electrodes of 2–4M resistance, using
series resistance compensation >80% to maintain voltage
error below 6mV.
Activation and inactivationwere analysed fromcurrents
recorded during a family of 500ms voltage pulses between
−80 and +80mV that were delivered at 0.17 Hz from
V hold of−100mV.Conductancewas calculatedbydividing
peak currents as a function of driving force, determined
by the Goldman–Hodgkin–Katz equation (Clay, 2000).
Inactivation of Kv4.2 was fitted with either the single
exponential function (Ae−t/τ +C), where t represents
time (ms), τ represents the time constant of decay, A
represents the inactivating component, and C is the
residual component of non-inactivating current; or the
dual-exponential function, (Af e−t/τf + Ase−t/τs +C), for
which τf and τs represent the fast and slow time constants,
and Af and As reflect the weighted components of
fast and slow decay, respectively. Comparison of the
single-exponential to dual-exponential decaywasmade by
modelling inactivation from the experimentally derived
variables and comparing the time to reach 1/e of the
peak current. The steady-state inactivation of Kv4.2 was
examined from a holding potential of −100mV with test
pulses delivered at 0.2 Hz from −120 to 0mV, held for
2.5 s followed by a brief pulse to +40mV to measure
current from non-inactivated channels. Recovery from
inactivation was measured by a two-pulse protocol with
a variable interpulse interval at −100mV. The per cent
recovery (R) was based on the difference between the first
plateau current (C1) and the second peak current (P2), as
compared to the inactivation that followed the first peak
current (P1): R= 100% ∗ (P2 −C1)/(P1 −C1).
Biochemistry
Pellets of harvested cells were solubilized for 45min
in lysis buffer containing (in mM): 100 NaCl, 40 KCl,
20 K-Hepes, 1 Na-EDTA, 10% v/v glycerol, 1% Triton
X-100 (Roche Applied Science, Indianapolis, IN, USA)
and protease-inhibitor tablets (Roche), pH 7.4. Insoluble
material was removed by centrifugation. Immuno-
purification of epitope-tagged proteins was performed
as before by Kim et al. (2004a) with anti-1d4
monoclonal antibody (National Cell Culture Center,
Minneapolis, MN, USA) linked to sepharose beads and
elution with 1mgml−1 1d4 peptide. MiRP3 purification
was performed by overnight incubation with rabbit
anti-MiRP3151−170 followed by adsorption to protein A
sepharose beads (Amersham Biosciences, Piscataway, NJ,
USA) and elution with 1mgml−1 antigenic peptide.
KChIP2 precipitation was similarly performed, except
that elution used 4% SDS. Cell lysates and purified
proteins were fractionated by SDS-PAGE and transferred
to nitrocellulose membranes for Western blotting. Blots
were imaged on a Licor Odyssey (Lincoln, NE, USA) using
fluorescent secondary antibodies.
Yeast two-hybrid assay
A 348 bp sequence corresponding to the 116 cyto-
plasmic residues of MiRP3 was inserted into a vector
optimized for the yeast two-hybrid assay, pDBleu, in
frame with the Gal4 binding domain. This bait plasmid
was stably incorporated into yeast, which were then
transformed with ∼1× 106 clones from a human heart
library containing a transcriptional-activation domain
(ProQuest library, Invitrogen) and screened for their
ability to grow on His− medium. Strong interactors
were validated by co-transformation into yeast with the
original bait plasmid and screened by ability to grow on
Ura− medium, 5-flouro-orotic acid sensitivity and β-Gal
activity.
Results
Kv4.2 and MiRP3 co-localize to T-tubules of rat
ventricle
Immunofluorescent labelling of MiRP3 and Kv4.2 was
performed in left ventricle sections of rat heart, and
confocal microscopy was used to reveal co-localization
of both proteins to the transverse tubules (Fig. 1). This
antibody pattern is consistent with prior localization of
Kv4.2 to the transverse tubule system (Takeuchi et al.
2000). The signal is shown to be specific for MiRP3 and
Kv4.2 because antibodies to separate epitopes of MiRP3
and Kv4.2 showed a similar staining pattern (N-14 and
AB5360, respectively; not shown) and peptide block of the
C© 2010 The Authors. Journal compilation C© 2010 The Physiological Society
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primary antibodies eliminated T-tubule staining (Fig. 1E
and F).
MiRP3 modulates Kv4.2 activity
Given the complexity of native cardiac cells, the functional
effect of MiRP3 on Kv4.2 was assessed by studies of
subunits expressed in tsA201 cells (Fig. 2 and Table 1), an
approach previously used by others to study the properties
of Kv4.2 with accessory subunits (Amarillo et al. 2008).
Whole-cell currents reveal MiRP3 to slow activation and
inactivation of Kv4.2 and to speed and enhance recovery
from inactivation.
Figure 2A shows representative macroscopic Kv4.2
currents in the absence and presence of MiRP3.
Current activation in response to a family of
depolarizing pulses is slowed by MiRP3 leading to
prolongation of the time required to reach peak current
magnitude (approximately doubled at +40mV). MiRP3
also produces a depolarizing shift of ∼+20mV in the
conductance–voltage relationship (Table 1).
MiRP3 slows Kv4.2 inactivation
The inactivating component of the outward current at
+40mV is well fitted with a dual-exponential decay
function and both the fast and slow time constants are
nearly doubled without affecting the weighting of the
fast versus slow decays. Consistent with effects of MiRP3
on activation and inactivation kinetics, the steady-state
inactivation of Kv4.2 is shifted by ∼10mV (Fig. 2B).
Further, MiRP3 speeds recovery from inactivation
∼30% and induces peak currents that exceed base-
line. Figure 2C shows a superimposed time series of
Kv4.2 current traces for pulse pairs separated by up to
3 s at −100mV. This overshoot phenomenon has been
described for native I to in human ventricular myocytes
(Wettwer et al. 1994) and observed upon expression of
MiRP1 with Kv4.2 in tissue-culture cells (Zhang et al.
2001).
MiRP3 alters the modulatory effects of KChIP2
on Kv4.2
The effects of KChIP2 on Kv4.2 have been described
previously in detail (An et al. 2000; Kuo et al. 2001;
Shibata et al. 2003). Kv4.2 and KChIP2 were co-expressed
in the absence and presence of MiRP3. Since KChIP2
increasesKv4.2 currents sodramatically, the concentration
of Kv4.2 cDNA was reduced in these experiments to pre-
vent current saturation. Figure 3 and Table 1 show that
Figure 1. Spatial co-localization of MiRP3 and Kv4.2 within rat heart
Confocal images of rat left ventricle probed with antibodies to MiRP3 (A) and Kv4 (B). The T tubules appear yellow
in the merged image (C). A differential interference contrast image (DIC, D) is provided for reference. Images E and
F show similarly obtained confocal images when antibodies to MiRP3 and Kv4.2, respectively, were preincubated
with blocking peptide; the blue colour reflects DAPI staining of nuclei. The white scale bar in B represents 20 μm.
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Table 1. Effect of MiRP3 expression on the biophysical properties of Kv4.2 or Kv4.2/KChIP2 in tsA201 cells
Without KChIP2 (n = 10–13) With KChIP2 (n = 16–21)
Control +MiRP3 P Control +MiRP3 P
Peak current density at +40 mV (pA pF−1) 660 ± 110 590 ± 90 0.65 1190 ± 220 890 ± 110 0.24
Time to peak (ms) 2.8 ± 0.2 5.8 ± 0.6 ∗ 3.1 ± 0.1 4.1 ± 0.3 ∗
Inactivation τf (ms) 14.2 ± 0.7 26.6 ± 1.9 ∗ 47.9 ± 1.7 50.0 ± 2.9 0.56
Inactivation τs (ms) 93.3 ± 7.7 146.7 ± 17 ∗ n/a n/a —
Weight of τf ((Af /(Af+As))∗100) (%) 80.8 ± 1.9 78.0 ± 3.7 0.46 n/a n/a —
Non-inactivated residual at 500 ms (%) 7.6 ± 0.6 10.4 ± 1.3 0.04 4.8 ± 0.7 6.7 ± 0.9 0.11
Half-max voltage of activation (V1/2-act; ms) −22.7 ± 1.4 −3.3 ± 2.5 ∗ −17.2± 0.6 −13.6 ± 1.1 ∗
Boltzmann width for V1/2-act (mV) 9.3 ± 0.3 14.2 ± 0.4 ∗ 8.6 ± 0.2 9.7 ± 0.3 ∗
Steady-state V1/2-inact (mV) −66.9 ± 1.2 −55.2±1.9 ∗ −53.4 ± 0.7 −53.0 ± 1.1 0.74
Boltzmann width for V1/2-inact (mV) 5.0 ± 1.2 6.1 ± 0.4 0.02 4.2 ± 0.2 5.4 ± 0.5 0.14
τ recovery from inactivation (ms) 74.5 ± 4.9 57.8 ± 5.1 0.047 21.8 ± 0.8 25.0 ± 2.0 0.14
Recovery overshoot (%) 0.0 ± 0.6 12.2 ± 2.2 ∗ 2.8 ± 0.3 1.9 ± 0.4 0.08
Values shown are for mean ± S.E.M. The P values are from two-tailed Student’s t test for equal variance, comparing the
absence versus presence of MiRP3. The ∗ indicates P < 0.01.
co-expression of MiRP3 and KChIP2 modifies the effects
of both accessory subunits. Thus, MiRP3 alone shifts
activation V 1/2 ∼20mV, KChIP2 alone shifts activation
V 1/2 ∼5mV and together the shift is an intermediate
∼10mV. MiRP3 alone speeds time to peak ∼100%,
KChIP2 alone speeds activation ∼10% and together the
shift is also intermediate,∼50% faster. MiRP3 alone slows
both fast and slow components of inactivation ∼100%,
KChIP2 alone slows inactivation ∼150% and such that
it proceeds in a monoexponential manner; with both
accessory subunits the channel inactivates as if KChIP2
is acting alone. MiRP3 on its own and KChIP2 alone shift
the steady-state inactivation V 1/2 ∼15mV and together
the change is ∼15mV, like either subunit on its own.
MiRP3 alone speeds recovery from inactivation∼30%and
produces overshoot; KChIP2 alone speeds recovery from
inactivation ∼350% and shows no significant overshoot.
With both accessory subunits, channels recover rapidly
without overshoot, as they do with KChIP2 alone.
MiRP3 and Kv4.2 form detergent-stable associations
Biochemical association between MiRP3 and Kv4.2 was
confirmed by expressing the two proteins in COS-7
cells using an epitope-tagged variant of human Kv4.2
(Kv4.2–1d4), a strategy we have used previously to
demonstrate co-assembly of Kv4.2 and KChIP2 (Kim et al.
2004a,b). Proteins were purified after detergent lysis of
cells viamonoclonal antibodies specific to the tag. Figure 4
shows MiRP3 and Kv4.2 are purified together indicating
they form detergent-stable complexes. Recovery is shown
to be specific because MiRP3 is not captured when the
channel has no tag or when MiRP3 or Kv4.2–1d4 are
expressed alone. Coassembly of Kv4.2 and MiRP3 within
the cells rather than secondarily after solubilization is
demonstrated by inability to co-purifyMiRP3 aftermixing
lysates of separate cells expressing Kv4.2–1d4 or MiRP3.
Multiple bands for MiRP3 reflect glycosylation of the
protein (Levy et al. 2008).
MiRP3 interacts with KChIP2 via Kv4.2
Lysates from tsA201 cells expressing Kv4.2–1d4, KChIP2
and MiRP3 were studied next (Fig. 5). Immuno-
purification via MiRP3 allows recovery of KChIP2 and
Kv4.2 (Fig. 5A, lane IPb). In contrast, KChIP2 is not
purified via MiRP3 when Kv4.2 is absent (Fig. 5A, lane
IPc); this demonstrates that the formation of a three-way
complex requires Kv4.2. Similar results were achieved
with an antibody to residues 136–150 of MiRP3 (not
shown). Immunoprecipitation of KChIP2 also allows for
recovery of MiRP3 and Kv4.2 (Fig. 5B, lane IPc). In this
case, however, a signal for the immature unglycosylated
form of MiRP3 is also seen in the absence of Kv4.2
(Fig. 5B, lane IPb); this suggests that the two accessory
subunits can interact in the absence of Kv4.2 in a location
away from the plasma membrane. This association was
not observed with either MiRP3 antibody (Fig. 5A, lane
IPc), apparently because those antibodies purified the
glycoslyated, membrane form of the protein, indicating
either that the two accessory subunits do not interactwhen
MiRP3 is mature or at this location.
MiRP3 interacts with filamin, but does not depend on
filamin to associate with Kv4.2
The ubiquitous cytoskeletal protein filamin A has been
shown to bind Kv4.2 and may be involved in chaperoning
the channel complex to various subcellular locations
(Petrecca et al. 2000). Therefore, a role for filamin A in
assembly of Kv4.2–MiRP3 complexes was evaluated. First,
an association of MiRP3 and filamin A was suggested by a
C© 2010 The Authors. Journal compilation C© 2010 The Physiological Society
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yeast two-hybrid screen; the screen also yielded sequences
for obscurin-like protein 1 (OBSL1; NM 015311) (Geisler
et al. 2007) and translin-associated factor X (TSNAX;
NM 005999) (Schroer et al. 2007) that were not
investigated any further. Next, association of MiRP3 and
filamin A was confirmed by co-immunoprecipitation in
COS-7 cells (Fig. 6A, lane IPc). It was demonstrated that
filaminA is not required for stable association ofKv4.2 and
MiRP3 by expression of the two subunits in a melanoma
cell line that lacks filamin A (M2) and in a control M2
line stably transfected with filamin A (A7) (Cunningham
et al. 1992), with successful co-immunopurification via
Kv4.2–1d4 in both cases (Fig. 6B).
Discussion
MinK-related peptides are accessory subunits that
modulate many properties of voltage-gated potassium
channels. They are widely expressed (McCrossan &
Abbott, 2004) and their promiscuous interactions with
ion channels (Abbott & Goldstein, 2002) suggest their
varied tissue-specific partners have yet to be identified. In
the myocardium, all five genes of the KCNE family are
transcribed (Lundquist et al. 2005, 2006; Radicke et al.
2006), although the functions of the family members
remain to be elucidated. The level of mRNA for KCNE4
(which encodes MiRP3) in human ventricle is higher
Figure 2. MiRP3 modulates Kv4.2 activity
A, representative macroscopic whole-cell recordings made from tsA201 cells transfected with hKv4.2 ± hMiRP3,
in response to a family of depolarizing pulses. Panel to the right shows Boltzmann fits to mean conductance values
(± S.E.M., n = 13 and 10, respectively). B, sample traces for +40 mV pulses delivered after a 2.5 s prepulse. Graph
shows Boltzmann fits to residual currents (relative to the first +40 mV pulse) as a function of the prepulse. C,
representative currents from a two-pulse protocol with a variable interpulse interval at –100 mV. Currents were
scaled so that the peak of the first pulse was 100%. Single-exponential fits to recovery from the two families
shown yielded τ values of 80.5 ms and 62.3 ms in the absence and presence of MiRP3, with plateaus overshooting
the first paired pulse by 0.1% and 10.9%, respectively. Fits to the mean per cent of recovery (± S.E.M.) are plotted
as a function of the interpulse interval.
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Figure 3. KChIP2 interferes with MiRP3 modulation of Kv4.2 kinetics
A–C, representative traces and fits to data (n = 16–21) obtained as described for Fig. 2, from tsA201 cells
transfected with hKChIP2.1/hKv4.2 cDNA (in pIRES) and either empty vector or hMiRP3.
than other members of the family (Lundquist et al. 2006;
Radicke et al. 2006) and found to be increased in human
heart failure in one study (Lundquist et al. 2005). Here, we
provide evidence suggesting a role forMiRP3 in formation
and operation of native cardiac I to via association with
Kv4.2 and KChIP2.
Supporting the participation of MiRP3 in the cardiac
I to current, MiRP3 and Kv4.2 were co-localized to
the T-tubules of murine ventricular myocytes. Further,
co-expression of the three proteins in tissue culture cells
leads to formation of detergent-stable ternary complexes
that can be purified with antibodies towards eitherMiRP3
or KChIP2. It was additionally noted that the cytoskeletal
scaffolding protein filamin A can assemble withMiRP3 or
Kv4.2 independently and is not required for their stable
assembly.
Figure 4. Stable biochemical interaction between
MiRP3 and Kv4.2
COS-7 cells transfected with MiRP3 (a), MiRP3 and
Kv4.2 (b), MiRP3 and Kv4.2–1d4 (c), or Kv4.2–1d4 alone
(d), were subjected to lysis and immunopurification (IP)
with anti-1d4 antibodies. An additional treatment
group (e) consisted of lysate from cells expressing MiRP3
mixed with lysate from cells expressing Kv4.2–1d4, at
4◦C for 16 h prior to immunopurification. Blots were
probed with antibodies to Kv4.2 (70 kDa) and MiRP3
(21–25 kDa).
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Studied in tsA201 cells in the absence ofKChIP2,MiRP3
alters Kv4.2 channel function, slowing activation and
inactivation, shifting V 1/2 for activation and inactivation,
speeding recovery from inactivation, and producing
overshoot. MiRP3 also alters the biophysical effects
of KChIP2 on channels formed with Kv4.2. Like
co-purification, these biophysical effects of MiRP3
indicate we are studying a novel population of channels
that contains all three subunits. Thus, study of a
mixture of Kv4.2–KChIP2 and Kv4.2–MiRP3 channels
would neither eliminate MiRP3-induced biexponential
inactivation kinetics nor overshoot in recovery from
inactivation (as if only Kv4.2–KChIP2 channels were
studied) while retaining MiRP3-induced slowing of
time to peak and shift in V 1/2 for activation
(Table 1). How these parameters may be altered in
their different, native cardiac milieu remains to be
clarified.
The spatial and temporal plasticity of I to across the
myocardial wall, the variety of accessory proteins
implicated in its operation, and the variation in
partnerships in different species and pathophysiological
conditions (Patel & Campbell, 2005; Niwa & Nerbonne,
2010) make it important to resolve the diverse roles of
accessory subunits in heart function; these same factors
make elucidation of the specific roles of each subunit a
challenge. Someaspects ofKCNE-family proteins function
in the heart have been elucidated. Evidence for assembly of
MinK and KCNQ1 to form cardiac IKs channels includes
comparison of native currents and those studied with
cloned subunits, clinical consequences of mutations in
KCNQ1 and KCNE1 genes, and the achievement of their
co-purification from horse cardiac tissue (Finley et al.
2002). MinK has also been implicated in the operation
of IKr channels (formed by hERG subunits) (McDonald
et al. 1997).
MiRP1 has been linked to the operation of IKr channels
with mutations and polymorphisms associated with
congenital and acquired long QT syndrome (Abbott et al.
1999; Sesti et al. 2000; Park et al. 2003), an association
demonstrated directly by co-isolation of MiRP1 and ERG
from dog heart (Jiang et al. 2004). In tissue culture
cells, MiRP1 has been implicated in modulation of the
Kv4.2/Kv4.3 (Zhang et al. 2001) subunits producing
I to and the hyperpolarization-activated cation channel
subunits that underlie I f (Yu et al. 2001; Proenza et al.
2002; Decher et al. 2003). Recently, targeted deletion of
MiRP1 in mice (which do not express abundant ERG
in adulthood) was found to cause moderate changes
in I to and IK,slow1, effects attributed to loss of impact
on murine Kv4.2 and Kv1.5 subunits, respectively, and
supported by co-immunoprecipitation of MiRP1–Kv4.2
and MiRP1–Kv1.5 complexes from normal mouse heart
(Roepke et al. 2008).
Figure 5. Ternary interactions between
MiRP3, Kv4.2 and KChIP2
A, MiRP3 was immunopurified from lysates of
tsA201 cells transfected with MiRP3 (a), MiRP3,
Kv4.2 and KChIP2 (b), MiRP3 and KChIP2 (c),
or Kv4.2 and KChIP2 (d). B, KChIP2 was
immunoprecipitated from lysates of tsA201
cells transfected with KChIP2 (a), MiRP3 and
KChIP2 (b), MiRP3, Kv4.2 and KChIP2 (c), Kv4.2
and KChIP2 (d), or MiRP3 and Kv4.2 (e). Images
of blots span roughly 65–80 kDa for Kv4.2,
24–31 kDa for KChIP, and 20–28 kDa for
MiRP3. Faint bands at 25–26 kDa in all five
lanes of the IP blotted for MiRP3 are presumed
to be crossreactivity of secondary antibodies to
immunoprecipitated KChIP2 antibody.
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MiRP2 also appears to participate in the modulation
of cardiac currents. Genetic studies have shown that
phenotype-positive members of a family with Brugada
syndrome carried an R99H missense mutation in KCNE3
and this was speculated (based on in vitro studies with
Kv4.2) to impact on I to (Delpo´n et al. 2008). This same
mutation of MiRP2 has been implicated in long QT
syndrome because in vitro studies showed it could reduce
currents passed by KCNQ1 (Ohno et al. 2009). Finally,
MiRP4 may also be involved in modulating cardiac ion
channels, as it too is expressed in heart and can inhibit
KCNQ1 and Kv4 channels in vitro (Angelo et al. 2002;
Bendahhou et al. 2005; Lundquist et al. 2005; Radicke
et al. 2006).
MiRP3 has previously been suggested to contribute
to the operation of cardiac IKs and I to. MiRP3 forms
a ternary complex with KCNQ1 and MinK in tissue
culture cells where it strongly suppresses IKs current
(Lundquist et al. 2005; Manderfield & George, 2008).
The high level of KCNE4 transcript in the heart seems
at odds with measurement of significant IKs currents.
However, modulation of IKs will depend on rates of
synthesis of MinK and MiRP3 and other cell-specific
factors that alter preferential assembly with KCNQ1
(Morin&Kobertz, 2007) as found forMiRP2withKv2.1 or
Kv3.1 in different cells in the nervous system (McCrossan
et al. 2003). Similar, cell-specific effects are expected for
MiRP3 and KChIP2 with Kv4.2. Radicke et al. (2006) have
previously implicatedMiRP3 in operation of human I to by
showing high levels of KCNE4 transcript in the heart that
change with cardiomyopathy and functional modulation
of channels formed by Kv4.3 and KChIP2. Perhaps due to
isoform differences, their findings vary from ours in that
theyobserveMiRP3 to speed time topeak current, to speed
inactivation, and to enhance recovery from inactivation
of Kv4.3 with KChIP2; whereas we observe MiRP3 to
slow time to peak and shift activation V 1/2 ∼5mV, while
the channels inactivate and recover from inactivation as
if KChIP2 is acting alone on Kv4.2. These differences
suggest specific roles for MiRP3 in cardiac repolarization
Figure 6. Interactions between filamin A,
MiRP3 and Kv4.2
A, COS-7 cells were transfected with fil–1d4
(a), MiRP3 and Kv4.2 (b), MiRP3, fil–1d4 and
Kv4.2 (c), MiRP3 and fil–1d4 (d), or fil–1d4 and
Kv4.2 (e). Cells were lysed and immunopurified
(IP) with anti-1d4 antibodies. Note that low
quantities of co-purified Kv4.2 required
high-sensitivity scanning to detect signal. B,
co-purification of MiRP3 with Kv4.2 in
filamin-replete (A7) and filamin-deplete (M2)
cells. Western blots show lysates and
epitope-purified fractions from cells transfected
with MiRP3 (a), Kv4.2–1d4 (b), or MiRP3 and
Kv4.2–1d4 (c).
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in cells that primarily employ Kv4.3, Kv4.2 or heteromeric
Kv4.2/Kv4.3 channels (Guo et al. 2002; Patel & Campbell,
2005).
Native-tissue co-immunoprecipitation is the most
convincing manner to establish the presence of subunit
partners as accomplished forMinK and KCNQ1 in equine
heart (Finley et al. 2002), MiRP1 and ERG in dog heart
(Jiang et al. 2004) and MiRP1 with Kv4.2 and Kv1.5 in
mouse heart (Roepke et al. 2008); this has not yet been
achieved with MiRP3. Given the dynamic expression of
the I to-related proteins across the wall of themyocardium,
adequate understanding of all these complexes may
require novel techniques to evaluate complexes fromsingle
cells.
How might MiRP3 influence I to currents? KCNE4 is
expressed uniformly and robustly across the ventricular
wall while Kv4.2 or KChIP2 vary in a species-dependent
manner (Bendahhou et al. 2005; Radicke et al. 2006).
As MiRP3 modifies operation of Kv4.2 differently when
it is assembled with KChIP2, the effects will vary in
spatial fashion with KChIP2. In channels with KChIP2,
MiRP3 should have only a modest inhibitory effect on
I to due to prolongation of the time to peak current
and the depolarizing shift of the V 1/2-act. In the absence
of KChIP2 one expects a different picture, notable for
marked reduction in I to due to loss of KChIP2-mediated
facilitation of Kv4.2 channel surface expression (Shibata
et al. 2003) and altered current morphology resulting
from MiRP3-induced slowing of activation, inactivation
of currents with biexponential kinetics and enhanced
recovery from inactivation. Thus, endocardial myocytes
with Kv4.2 and MiRP3 and little or no KChIP2 (Rosati
et al. 2001; Schultz et al. 2005) are those expected
to demonstrate these characteristics Similarly, KChIP2
transcript is reduced in human cardiomyopathic heart
while mRNA levels for the genes encoding Kv4 andMiRP3
appear to be relatively stable (Radicke et al. 2006). Under
these circumstances, MiRP3 may again serve to further
reduce andmodify the attributes of potassiumflux beyond
those that accrue from the absence of KChIP2, such as,
maintaining the slow inactivationkinetics of I to thatpersist
in congestive heart failure (Tomaselli et al. 1994; Wettwer
et al. 1994).
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